Chandra Bhagat Pharma Ltd

Chandra Bhagat Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Chandra Bhagat Pharma Ltd

₹ 115 2.77%
25 Apr - close price
cbcpharma.com BSE: 542934
About

Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures and trades Pharmaceutical Formulations and API Products[1]

Key Points

Business Overview:[1][2]
Company manufactures formulations and does trading of API in domestic and international markets through its own distribution network and Sales force, under the brand name CBC.
It manufactures formulations by outsourcing to third party on job work basis
a) Major focus on Injection viz. ITV (Intravenous) & IM (Intramuscular), tablets and capsules supply to Hospital and Health care Centre for critical diseases
b) Getting approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic and branded Pharma formulations and medicines to healthcare institution, Government, NGO’s, Hospitals & Distributors
c) Source, deal in Import, indenting and Supply in Specialty Chemicals, Intermediates & Active Pharmaceuticals Ingredients (API)

Website BSE
  • Market Cap ₹ 86.6 Cr.
  • Current Price ₹ 115
  • High / Low ₹ 160 / 80.0
  • Stock P/E 74.1
  • Book Value ₹ 37.3
  • Dividend Yield 0.00 %
  • ROCE 7.13 %
  • ROE 3.36 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 54.3 to 25.0 days.
  • Company's working capital requirements have reduced from 182 days to 123 days

Cons

  • Stock is trading at 3.08 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 4.28% over past five years.
  • Company has a low return on equity of 2.40% over last 3 years.
  • Earnings include an other income of Rs.7.20 Cr.
  • Promoter holding has decreased over last 3 years: -3.03%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023
22 48 43 51 44 75 119
21 47 42 50 43 74 124
Operating Profit 2 2 2 1 1 2 -5
OPM % 7% 3% 4% 2% 2% 2% -4%
0 0 0 1 1 0 7
Interest 2 2 1 2 1 1 1
Depreciation 0 0 0 0 0 0 0
Profit before tax 0 0 1 1 1 1 1
Tax % 25% 33% 24% 31% 31% 15% 32%
0 0 0 0 0 1 1
EPS in Rs 0.04 0.21 0.57 0.48 0.49 0.72 0.83
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
20 35 48 61 80 90 97 106 94 71 94 120 195
19 35 46 58 76 85 92 102 91 67 91 116 198
Operating Profit 1 0 2 3 3 4 5 5 3 4 3 3 -3
OPM % 7% 1% 4% 5% 4% 5% 5% 4% 3% 5% 3% 3% -2%
0 0 1 0 0 0 1 0 0 0 2 0 7
Interest 1 0 2 2 3 4 4 4 3 4 3 2 2
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 1
Profit before tax 0 0 0 1 1 1 2 1 0 0 1 1 2
Tax % -135% 27% 17% 39% 51% 27% 33% 22% 26% 32% 27% 22%
0 0 0 0 0 1 1 1 0 0 1 1 1
EPS in Rs 16.00 9.60 8.37 10.29 8.37 15.79 24.64 10.29 0.41 0.25 1.06 1.21 1.55
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 4%
3 Years: 8%
TTM: 104%
Compounded Profit Growth
10 Years: 14%
5 Years: -2%
3 Years: 43%
TTM: 60%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 32%
1 Year: 0%
Return on Equity
10 Years: 4%
5 Years: 3%
3 Years: 2%
Last Year: 3%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0 0 0 0 0 0 0 1 8 8 8 8 8
Reserves 3 3 6 6 6 7 8 14 18 18 19 20 21
11 11 19 28 28 22 22 31 30 27 21 19 18
9 9 7 8 10 26 28 37 19 19 25 14 14
Total Liabilities 22 24 32 42 44 56 58 83 75 72 72 61 60
1 1 1 1 1 1 1 0 0 0 0 1 2
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 5 1 4 1 0 0 0 0
21 23 31 41 44 51 56 78 74 71 72 60 58
Total Assets 22 24 32 42 44 56 58 83 75 72 72 61 60

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0 0 0 0 0 -9 -6 4 -7 8 12 5
0 0 0 0 0 0 -0 -0 0 0 0 -0
0 0 0 0 0 8 7 -4 7 -6 -10 -4
Net Cash Flow 0 0 0 0 0 -1 -0 -0 -0 2 3 1

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 149 85 65 71 66 80 67 90 54 80 58 25
Inventory Days 220 161 177 123 133 145 174 187 215 153 100
Days Payable 180 53 43 33 81 69 117 53 79 12 11
Cash Conversion Cycle 190 85 174 205 156 132 143 146 188 216 199 114
Working Capital Days 167 107 149 166 134 125 138 139 212 258 165 123
ROCE % 12% 2% 12% 10% 10% 15% 17% 13% 7% 7% 9% 7%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024
70.42% 70.42% 71.80% 71.80% 70.11% 69.09% 68.24% 68.69% 68.77%
0.00% 0.00% 0.00% 0.00% 0.00% 0.85% 0.85% 1.33% 1.33%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.89% 0.89%
29.58% 29.58% 28.20% 28.20% 29.89% 30.07% 30.91% 29.09% 29.02%
No. of Shareholders 17815610690126126146134151

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings